Skip to main content
Kukje Pharma Co., Ltd. logo

Kukje Pharma Co., Ltd. — Investor Relations & Filings

Ticker · 002720 ISIN · KR7002720001 KO Manufacturing
Open in API
Filings indexed 299 across all filing types
Latest filing 2026-05-29 Major Shareholding Noti…
Country KR South Korea
Listing KO 002720

About Kukje Pharma Co., Ltd.

https://www.kukjepharm.co.kr/index.php?…

Kukje Pharma Co., Ltd. is a company engaged in the manufacturing, distribution, import, and export of pharmaceutical products, cosmetics, and health supplements. Its core offerings include a wide range of prescription (ETC) and over-the-counter (OTC) drugs, with a notable specialization in antibiotics such as Cephalosporins. In addition to its primary pharmaceutical business, the company also develops and markets cosmetic products, food supplements, and respiratory protection face masks. The company serves both domestic and international markets.

Recent filings

Filing Released Lang Actions
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 92% confidence The document is a detailed statutory report under Korea’s Capital Markets Act (Form 147) disclosing large-volume shareholdings, changes in major share ownership by insiders and related parties, including share counts, percentages, and transaction details. This matches a Major Shareholding Notification rather than an earnings release or AGM material.
2026-05-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 98% confidence The document is a Korean "임원·주요주주 특정증권등 소유상황보고서," which details personal shareholdings and transactions by an executive (김영관) and is filed with the securities regulator and stock exchange. This is a standard insider ownership change report, matching the definition of a Director's Dealing report (insider trading/insider share transactions).
2026-05-29 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 84% confidence The document is an insider ownership report filed by an executive ('임원ㆍ주요주주 특정증권등 소유상황보고서'), detailing the reporter’s personal transactions in company shares, number of shares held, and changes over time. This corresponds to a director’s dealing disclosure (insider trades).
2026-05-27 Korean
[기재정정]타인에대한채무보증결정
Capital/Financing Update Classification · 85% confidence The document is a formal corporate announcement of a debt guarantee decision (and its correction) for an affiliate, detailing guarantee amounts, periods, board resolution dates and related financial ratios. It does not contain general financial statements or investor presentation material, nor is it about share issuance or buybacks. It is a financing‐related regulatory update on contingent liabilities (debt guarantee), which best fits the Capital/Financing Update category (CAP).
2026-05-20 Korean
분기보고서 (2026.03)
Interim / Quarterly Report Classification · 93% confidence The document is titled “분기보고서” (Quarterly Report) for the 69th fiscal period covering 2026-01-01 to 2026-03-31. It contains comprehensive financial statements, business overview, Q1 revenue, profit figures, asset tables, and detailed analysis. It is the actual interim financial report itself, not merely an announcement or certification. Therefore it is classified as an Interim/Quarterly Report. Q1 2026
2026-05-15 Korean
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Board/Management Information Classification · 95% confidence The document is a filing to the Korean Financial Supervisory Service/Korea Exchange reporting the appointment, dismissal, or mid-term retirement of outside directors. This is a direct announcement of changes in the company’s board of directors (outside directors). Therefore, it falls under Board/Management Information.
2026-03-26 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.